Cheng‐Jung Ho

SGLT2i use and fracture risk compared with DPP4i in patients with T2DM

ABSTRACT Introduction The association between sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) use and fracture risk remains inconclusive. Most previous studies have focused on treatment‐naïve patients, despite many patients in routine clinical practice initiating SGLT2i therapy...